Zydus Wellness Q1 results: The company’s flagship brands, Glucon-D, Nycil, Everyuth Peel-off, and Scrub, continued to dominate their respective categories

Zydus Wellness Q1 profit surges 33.78% amidst strong brand performance

Zydus Wellness consolidated net profit rises 33.79% in the June 2024 quarter

Zydus Wellness introduces Complan Immuno-Gro in Tamil Nadu with Ayurvedic herbs, targeting children’s immunity, backed by brand ambassador Sneha.

Zydus Wellness expands its Complan portfolio with new launch

The Indian market closed lower on Monday as traders preferred to remain on the sidelines in the run up to Budget 2024. The S&P BSE Sensex fell over 100 points while Nifty50 closed above 24,500 levels. Market Roundup

Technical Breakout Stocks: Alembic Pharma, Dr Lal PathLabs and Zydus Wellness hit 52-week highs; what should traders do? - Market Roundup

The management sees encouraging signs of industry recovery, with inflation stabilising and margins poised for improvement.

Zydus Wellness stock jumps 5%; hits 2-year high on hopes of demand recovery

Zydus Family Trust and SBI Mutual Fund were the buyers of Zydus Wellness shares.

PE Firm True North Sells Stake In Zydus Wellness Worth Rs 127 Crore

ICICI Securities is bullish on Zydus Wellness recommended buy rating on the stock with a target price of Rs 1800 in its research report dated November 07, 2023.

Buy Zydus Wellness; target of Rs 1800: ICICI Securities

Sharekhan is bullish on Zydus Wellness has recommended buy rating on the stock with a target price of Rs 1800 in its research report dated November 06, 2023.

Buy Zydus Wellness; target of Rs 1800: Sharekhan

​​Zydus Wellness Products, which manufactures and sells energy drink GLUCON-C and GLUCON-D, had alleged that Cipla Health’s Gluco-C and Gluco-D were deceptively similar to its registered trademarks.

HC restrains Cipla from using ‘Gluco-C’ or ‘Gluco-D’ trademarks

In a move that is brings relief to Zydus Wellness, the Delhi High Court has restrained Cipla Health from using brands Gluco-C and Gluco-D

Delhi HC restrains Cipla Health from using marks Gluco-C, Gluco-D

For FY23, the Glucon-D maker’s standalone net profit stood at ₹66 crore, a 400 percent jump from the previous fiscal

Zydus Wellness gains after Norges Bank sells stake

Hasn't fared well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Zydus Wellness Limited is an integrated consumer company, engaged in the development, production, marketing and distribution of health and wellness products.